Takeshi Matsunobu Selected Research

Takeshi Matsunobu Research Topics

6	Noise-Induced Hearing Loss (Acoustic Trauma) 01/2016 - 06/2009
2	Carcinoma (Carcinomatosis) 09/2021 - 01/2013
2	IGA Glomerulonephritis (IGA Nephropathy) 06/2021 - 12/2013
2	Sensorineural Hearing Loss 01/2016 - 01/2012
2	Shock 01/2016 - 12/2014
2	Barotrauma 01/2011 - 07/2009
1	Parotitis (Parotiditis) 01/2022
1	Xerostomia 01/2022
1	Pathologic Constriction (Stenosis) 01/2022
1	Chronic Renal Insufficiency 06/2021
1	Inappropriate ADH Syndrome (SIADH) 03/2021
1	Vasculitis (Vasculitides) 02/2021
1	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 02/2021
1	Otitis Media 02/2021
1	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 02/2021
1	Microscopic Polyangiitis 02/2021
1	Ototoxicity 10/2016
1	Neoplasms (Cancer) 02/2016
1	Osteonecrosis (Kienbock's Disease) 02/2016
1	Osteoporosis 02/2016
1	Multiple Myeloma 02/2016
1	Neoplasm Metastasis (Metastasis) 02/2016
1	Breast Neoplasms (Breast Cancer) 02/2016
1	Hypercalcemia (Milk Alkali Syndrome) 02/2016
1	Blast Injuries 01/2016
1	Conductive Hearing Loss 01/2016
1	Salivary Gland Calculi (Sialolithiasis) 12/2014
1	Glomerulonephritis 12/2013
1	Head and Neck Neoplasms (Head and Neck Cancer) 08/2013
1	Asthenia 01/2013
1	Bacterial Infections (Bacterial Infection) 01/2012
1	Virus Diseases (Viral Diseases) 01/2012
1	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 01/2012
1	Paralysis (Palsy) 09/2011
1	Alzheimer Disease (Alzheimer's Disease) 01/2011
1	Gastroesophageal Reflux (GERD) 01/2010
1	Globus Sensation 01/2010
1	Wounds and Injuries (Trauma) 06/2009

2	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2016 - 12/2014
2	Therapeutic UsesIBA 12/2013 - 07/2009
1	Immunoglobulin G (IgG)IBA 01/2022
1	Immunoglobulin A (IgA)IBA 06/2021
1	SteroidsIBA 06/2021
1	Vasopressins (Vasopressin)IBA 03/2021
1	Myeloblastin (Proteinase 3)IBA 02/2021
1	Peroxidase (Myeloperoxidase)IBA 02/2021
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 02/2021
1	8-Hydroxy-2'-DeoxyguanosineIBA 10/2016
1	Caspase 3 (Caspase-3)IBA 10/2016
1	Diphosphonates (Bisphosphonates)IBA 02/2016
1	Bone Density Conservation AgentsIBA 02/2016
1	phytobacteriomycin (PBM)IBA 01/2016
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2016
1	Protein Isoforms (Isoforms)IBA 11/2015
1	HydrogenIBA 12/2014
1	Protein CIBA 10/2014
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 10/2014
1	CytokinesIBA 01/2012
1	Proteins (Proteins, Gene)FDA Link 09/2011
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 09/2011
1	Neuroprotective AgentsIBA 01/2011
1	1-(3-(2-(1-benzothiophen-5-yl) ethoxy) propyl)-3-azetidinol maleateIBA 01/2011
1	maleic acid (maleate)IBA 01/2011
1	BariumIBA 01/2010
1	EdaravoneIBA 07/2009
1	Heme Oxygenase-1IBA 06/2009
1	Free RadicalsIBA 06/2009

4	Therapeutics 01/2022 - 08/2013
3	Lasers (Laser) 01/2016 - 01/2013
2	Radiotherapy 01/2022 - 01/2013
2	Tonsillectomy 06/2021 - 12/2013
2	Low-Level Light Therapy (LLLT) 01/2016 - 05/2015
1	Free Tissue Flaps 09/2021
1	Surgical Flaps 09/2021
1	Minimally Invasive Surgical Procedures 12/2014
1	Drug Therapy (Chemotherapy) 08/2013
1	Chemoradiotherapy 01/2013
1	Oral Administration 01/2011